Evaluation of the efficacy and safety of the use of acupuncture for the adjuvant treatment of patients with post-stroke cognitive impairment: protocol for a randomized controlled trial
Autor: | Xudong Yu, Tianyu Cao, Ruijia Liu, Bowen Liu, Yue Wang, Ye Liu, Hongwei Yuan, Jisheng Wang, Xinwei Li |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
medicine.medical_treatment MEDLINE Acupuncture Therapy Medicine (miscellaneous) law.invention 03 medical and health sciences Study Protocol 0302 clinical medicine Randomized controlled trial law Acupuncture Medicine Humans Pharmacology (medical) Cognitive Dysfunction 030212 general & internal medicine Cognitive impairment Randomized Controlled Trials as Topic Protocol (science) lcsh:R5-920 Mini–Mental State Examination medicine.diagnostic_test business.industry Stroke Rehabilitation Mental Status and Dementia Tests Test (assessment) Stroke Treatment Outcome Physical therapy business lcsh:Medicine (General) Adjuvant 030217 neurology & neurosurgery |
Zdroj: | Trials, Vol 21, Iss 1, Pp 1-8 (2020) Trials |
ISSN: | 1745-6215 |
Popis: | Background Post-stroke cognitive impairment (PSCI) is a series of syndromes that meet the diagnostic criteria for cognitive impairment that appear after a stroke. The treatment of PSCI with oral drugs alone is not ideal and has obvious side effects. Therefore, complementary and alternative treatments are needed for patients with insufficient or significant side effects of oral medications. Therefore, we will evaluate the clinical effectiveness and safety of acupuncture in the treatment of PSCI. Methods/design In this study, patients will be randomly divided into two groups. Intervention group: acupuncture combined with oral medication. Control group: Western medicine treatment plan. All participants will continue to receive conventional drug treatment. The selection of outcomes will be evaluated by Mini Mental State Examination Scale (MMSE) at week 12. The scale will be conducted by two well-trained reviewers who will conduct joint MMSE inspections on participants. The test time will be selected 3 days before treatment and once 4 weeks after treatment. After the MMSE test, the two raters scored independently, and the average of the two was used as the final score. Discussion This trial may provide evidence regarding the clinical effectiveness, safety, and cost-effectiveness of acupuncture for patients with PSCI. Trial registration ClinicalTrials.gov ChiCTR2000029926. Registered on 17 February 2020 http://www.chictr.org.cn/showproj.aspx?proj=49356 |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |